ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Trial details
- Registry ID
- NCT05081245
- Phase
- Phase 2
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)NCT05081245 | MapLight Therapeutics | Phase 2 | Completed | 2026-03-10Actual |
| ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273 | MapLight Therapeutics | Phase 2 | Active not recruiting | 2027-11Estimated |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192 | MapLight Therapeutics | Phase 2 | Recruiting | 2027-12Estimated |
| A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaNCT07038876 | MapLight Therapeutics | Phase 2 | Completed | 2026-06-04Actual |
| A Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaNCT07459647 | MapLight Therapeutics | Phase 2 | Recruiting | 2030-02Estimated |
| An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisNCT07459660 | MapLight Therapeutics | Phase 2 | Enrolling by invitation | 2029-03Estimated |
NCT07459660 · MapLight Therapeutics
Recruiting
Enrolling by invitation
NCT05889273 · MapLight Therapeutics
Enrolling by invitation
Active not recruiting
NCT07038876 · MapLight Therapeutics
Estimated
Actual
Aug 2026
4 Jun 2026
Active not recruiting
Completed
NCT05081245 · MapLight Therapeutics
Estimated
Actual
150 participants (planned)
168 participants (actual)
Estimated
Actual
Oct 2026
10 Mar 2026
Active not recruiting
Completed
NCT07038876 · MapLight Therapeutics
Estimated
Actual
300 participants (planned)
307 participants (actual)
Recruiting
Active not recruiting
NCT07459647 · MapLight Therapeutics
Not yet recruiting
Recruiting
NCT07459660 · MapLight Therapeutics
Not yet recruiting
Recruiting
NCT07038876 · MapLight Therapeutics
Jan 2027
Aug 2026
NCT06887192 · MapLight Therapeutics
Feb 2027
Dec 2027
NCT05081245 · MapLight Therapeutics
Recruiting
Active not recruiting